Literature DB >> 33576273

Targeting the SARS-CoV-2 3CLpro and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors.

Milad Shirvaliloo1,2.   

Abstract

Entities:  

Keywords:  3CLpro; COVID-19; NO/cGMP; PDE5; PDE5 inhibitors; SARS-CoV-2; sildenafil; tadalafil; thromboembolism

Year:  2021        PMID： 33576273      PMCID： PMC7885524          DOI： 10.2217/fca-2020-0201

Source DB:  PubMed          Journal:  Future Cardiol        ISSN： 1479-6678


× No keyword cloud information.
  17 in total

1.  Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.

Authors:  Ana Karolina Santana Nunes; Catarina Rapôso; Sura Wanessa Santos Rocha; Karla Patrícia de Sousa Barbosa; Rayana Leal de Almeida Luna; Maria Alice da Cruz-Höfling; Christina Alves Peixoto
Journal:  Brain Res       Date:  2015-09-25       Impact factor: 3.252

2.  Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging.

Authors:  Elisa Giannetta; Andrea M Isidori; Nicola Galea; Iacopo Carbone; Elisabetta Mandosi; Carmine D Vizza; Fabio Naro; Susanna Morano; Francesco Fedele; Andrea Lenzi
Journal:  Circulation       Date:  2012-04-11       Impact factor: 29.690

3.  Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease.

Authors:  Zhen Qiao; Hongtao Zhang; Hai-Feng Ji; Qian Chen
Journal:  Computation (Basel)       Date:  2020-05-31

Review 4.  Structure, Function, and Evolution of Coronavirus Spike Proteins.

Authors:  Fang Li
Journal:  Annu Rev Virol       Date:  2016-08-25       Impact factor: 10.431

5.  Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

Authors:  C M Chu; V C C Cheng; I F N Hung; M M L Wong; K H Chan; K S Chan; R Y T Kao; L L M Poon; C L P Wong; Y Guan; J S M Peiris; K Y Yuen
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

6.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.

Authors:  Zhenming Jin; Xiaoyu Du; Yechun Xu; Yongqiang Deng; Meiqin Liu; Yao Zhao; Bing Zhang; Xiaofeng Li; Leike Zhang; Chao Peng; Yinkai Duan; Jing Yu; Lin Wang; Kailin Yang; Fengjiang Liu; Rendi Jiang; Xinglou Yang; Tian You; Xiaoce Liu; Xiuna Yang; Fang Bai; Hong Liu; Xiang Liu; Luke W Guddat; Wenqing Xu; Gengfu Xiao; Chengfeng Qin; Zhengli Shi; Hualiang Jiang; Zihe Rao; Haitao Yang
Journal:  Nature       Date:  2020-04-09       Impact factor: 49.962

Review 7.  COVID-19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019-nCoV disease.

Authors:  Roghayeh Sheervalilou; Milad Shirvaliloo; Nahid Dadashzadeh; Sakine Shirvalilou; Omolbanin Shahraki; Younes Pilehvar-Soltanahmadi; Habib Ghaznavi; Samideh Khoei; Ziba Nazarlou
Journal:  J Cell Physiol       Date:  2020-05-26       Impact factor: 6.513

8.  Sildenafil Reduces Neointimal Hyperplasia after Angioplasty and Inhibits Platelet Aggregation via Activation of cGMP-dependent Protein Kinase.

Authors:  Han-Mo Yang; Sooryeonhwa Jin; Hyunduk Jang; Ju-Young Kim; Joo-Eun Lee; Joonoh Kim; Hyo-Soo Kim
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

9.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

10.  Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. The DEDALO project.

Authors:  Andrea M Isidori; Elisa Giannetta; Riccardo Pofi; Mary A Venneri; Daniele Gianfrilli; Federica Campolo; Claudio M Mastroianni; Andrea Lenzi; Gabriella d'Ettorre
Journal:  Andrology       Date:  2020-07-03       Impact factor: 4.456
View more
  3 in total

Review 1.  Drugs for paediatric hyperinflammatory syndromes.

Authors:  Kam Lun Hon; Alexander Kc Leung; Wing Hang Leung; Karen Ka Yan Leung; Kai Ning Cheong; Pamela Pw Lee
Journal:  Drugs Context       Date:  2022-05-27

Review 2.  Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19?

Authors:  Rakesh C Kukreja; Rui Wang; Saisudha Koka; Anindita Das; Arun Samidurai; Lei Xi
Journal:  Mol Cell Biochem       Date:  2022-08-29       Impact factor: 3.842

3.  Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma.

Authors:  Laura Cursi; Francesca Ippolita Calo Carducci; Sara Chiurchiu; Lorenza Romani; Francesca Stoppa; Giulia Lucignani; Cristina Russo; Daniela Longo; Carlo Federico Perno; Corrado Cecchetti; Mary Haywood Lombardi; Patrizia D'Argenio; Laura Lancella; Stefania Bernardi; Paolo Rossi
Journal:  Int J Environ Res Public Health       Date:  2021-12-15       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.